Table 2.

Clinical and laboratory characteristics of the Patients COVID-19 and acute cerebrovascular syndromes.

Characteristics	Patient-1	Patient-2	Patient-3	Patient-4	Patient-5	Patient-6	Patient-7	Patient-8
Age	31	57	81	72	67	47	60	72
Acute Cerebrovascular Syndrome Characteristics	RCVS with Convexity SAH in setting of intracranial and extracranial Dissection	Large vessel occlusion stroke secondary to extracranial dissection with status post mechanical thrombectomy	Extracranial and intracranial dissection with diffuse subarachnoid hemorrhage	Embolic stroke of undetermined source (ESUS) followed by acute onset cerebral venous thrombosis (CVT) in the right transverse sinus and jugular bulb.	Embolic stroke of undetermined source (ESUS)	Embolic stroke of undetermined source (ESUS)	Embolic stroke of undetermined source (ESUS)	Embolic stroke of undetermined source (ESUS)
Gender	Female	Female	Male	Female	Female	Male	Male	Female
WBC	7.2	13.8	7.4	0.2	11.4	10.1	6.4	8.6
Neutrophils	59	15.7	86.7	85	84	70.9	52.9	65.4
Lymphocytes	29.8	76.4	6.9	10	6	17.4	32	22.3
Platelets	242	270	205	9	406	323	262	124
C- Reactive Protein	1.5	38	17		34	<0.1		5.2
Creatinine	0.79	0.72	2.26	0.85	2.19	1.87	0.81	0.68
BUN	22	10	49	71	85	25	18	17
Creatine Kinase	66	62	173	189	1561	270		1919
LDH	316	527	334	779	896			303
AST	17	64	16	139	461	57	33	33
ALT	13	23	10	189	534	55	73	19
D-Dimer	1.27	7.79	>35	>35	>35	0.19
Ferritin	151.4	4311.3	772.8		10941	77.6		773.9
Covid19 Severity	Mild	Severe	Severe	Severe	Mild	Mild	Severe	Severe
Procalcitonin	Negative	0.93	Negative	Negative	7.85	Negative	Negative	Negative
Fibrinogen	491	732	440	856	836	666	499	519

WBC (White Blood Cells) RCVS (Reversible cerebral vasoconstriction syndrome); SAH (Subarachnoid Hemorrhage); ESUS (Embolic stroke of undetermined source); ALT (alanine aminotransaminase); AST (aspartate transaminase); LDH (lactate dehydrogenase).